These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16533797)

  • 1. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
    Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents and HIV vaccine trials: what are the clinical trial site issues?
    Bekker LG; Jaspan H; McIntyre J; Wood R; Gray G
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):93-7. PubMed ID: 16533798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual activity and contraceptive use: the components of the decisionmaking process.
    Gage AJ
    Stud Fam Plann; 1998 Jun; 29(2):154-66. PubMed ID: 9664629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.
    Schüklenk U; Ashcroft R
    Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of sexual abuse on HIV-related attitudes and behaviors in adolescent psychiatric inpatients.
    Brown LK; Kessel SM; Lourie KJ; Ford HH; Lipsitt LP
    J Am Acad Child Adolesc Psychiatry; 1997 Mar; 36(3):316-22. PubMed ID: 9055511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
    Slack CM
    Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
    [No Abstract]   [Full Text] [Related]  

  • 8. (Un)risky business: adolescents and HIV prevention trials.
    Philpott S
    Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207
    [No Abstract]   [Full Text] [Related]  

  • 9. South African adolescents: pathways to risky sexual behavior.
    Brook DW; Morojele NK; Zhang C; Brook JS
    AIDS Educ Prev; 2006 Jun; 18(3):259-72. PubMed ID: 16774467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
    Snyder J; Miller CL; Gray G
    Am J Bioeth; 2011 Jun; 11(6):W1-3. PubMed ID: 21678202
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of HIV+ and HIV- adolescents: risk factors and psychosocial determinants.
    Hein K; Dell R; Futterman D; Rotheram-Borus MJ; Shaffer N
    Pediatrics; 1995 Jan; 95(1):96-104. PubMed ID: 7770318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related attitudes and risk behavior of young adolescent mothers.
    Brown LK; Lourie KJ; Flanagan P; High P
    AIDS Educ Prev; 1998 Dec; 10(6):565-73. PubMed ID: 9883291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adaptation of the Health Belief Model for the prevention of HIV infection].
    van Wyk NC; Basson PM
    Curationis; 1994 Aug; 17(3):44-50. PubMed ID: 7987960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Youth risk behavior survey: Bangkok, Thailand.
    Ruangkanchanasetr S; Plitponkarnpim A; Hetrakul P; Kongsakon R
    J Adolesc Health; 2005 Mar; 36(3):227-35. PubMed ID: 15737779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
    Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
    Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
    Starace F; Embrione F; Fusco ML; Cafaro L
    Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral risk in early adolescents with HIV+ mothers.
    Mellins CA; Brackis-Cott E; Dolezal C; Meyer-Bahlburg HF
    J Adolesc Health; 2005 Apr; 36(4):342-51. PubMed ID: 15780790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why don't young adults protect themselves against sexual transmission of HIV? Possible answers to a complex question.
    Keller ML
    AIDS Educ Prev; 1993; 5(3):220-33. PubMed ID: 8217474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why has HIV stabilized in South Africa, yet not declined further? Age and sexual behavior patterns among youth.
    Katz I; Low-Beer D
    Sex Transm Dis; 2008 Oct; 35(10):837-42. PubMed ID: 18607312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.